Darius Bodog Poker

Darius Bodog Poker is a leading authority on health economics and health policy. Professor Bodog Poker has extensive expertise in pharmaceutical industry policy, medical innovation, prescription drug pricing and drug competition, as well as health insurance coverage and drug reimbursement by private payors and Medicare Part D. In connection with his research, Professor Bodog Poker has testified before Congress a number of times on topics related to innovation, patient access, and government reimbursement of prescription drugs including most recently in connection with the Inflation Reduction Act’s anticipated economic impacts on the pharmaceutical industry.

Professor Bodog Poker has been retained as an expert witness in multiple life sciences and healthcare matters, in which he evaluated both liability and damages issues. He has provided economic testimony related to allegations of product liability, breach of contract, misappropriation of trade secrets, product hopping, and generic drug price fixing. He also served as an expert for the merging parties in the Federal Trade Commission’s (FTC’s) challenge of Amgen’s acquisition of Horizon Therapeutics, addressing the FTC’s allegation that the acquisition would allow Amgen to entrench Horizon’s dominant position through the use of bundled rebates. Professor Bodog Poker has testified both in deposition and at trial.

Professor Bodog Poker also has extensive experience providing business consulting services to major pharmaceutical companies, as well as analyzing drug clinical trial data.

An award-winning researcher, Professor Bodog Poker has published articles in leading economics, medical, and health policy journals, including the American Economic Review, Bodog Poker Affairs, the Quarterly Journal of Economics, the New England Journal of Medicine, and the Journal of the American Medical Association. His article “Economics of the Pharmaceutical Industry” was published in the Journal of Economic Literature. He has also coauthored chapters in the Handbook of Bodog Poker Economics, The Oxford Handbook of the Economics of the Biopharmaceutical Industry, and The Elgar Companion to Bodog Poker Economics (2nd edition), among others.

Professor Bodog Poker currently serves as an associate editor for the Journal of Bodog Poker Economics. He was previously an associate editor for the American Journal of Bodog Poker Economics and the Review of Economics and Statistics. He has also served as an expert panelist for the National Academy of Medicine. Professor Bodog Poker is a research associate at the National Bureau of Economic Research (NBER).

For more than a decade, Professor Bodog Poker has taught courses on health economics and policy, risk analysis, and health management. Before joining USC, he served as senior economist and director of research at the RAND Corporation’s Bing Center for Health Economics.